Client News

[at noodls] - c3a3ba79-6279-4504-a37b-9c22b16a97e1.pdf PRESS RELEASE Lyon and Indianapolis, May 31, 2016 - Adocia (Euronext Paris: ADOC) and Eli Lilly and Company (NYSE: LLY) announced today positive topline results ...
Posted: May 31, 2016, 4:13 pm
Posted: May 27, 2016, 3:40 pm
Posted: May 27, 2016, 8:58 am
[Reuters - UK Focus] - Analysts said the drug's launch would now likely be delayed until 2017 after the British drugmaker said the Food and Drug Administration (FDA) had issued a so-called complete response letter (CRL) for ZS-9, or sodium zirconium cyclosilicate. "The CRL refers to observations arising from a pre-approval manufacturing inspection," AstraZeneca said. "The FDA also acknowledged receipt of recently submitted data which it has yet to review.
Posted: May 27, 2016, 8:53 am
[Reuters - UK Focus] - AstraZeneca said on Friday U.S. regulators would not approve its new drug for high potassium levels at present due to a manufacturing issue, dealing a blow to a product acquired when it bought ZS Pharma ...
Posted: May 27, 2016, 6:36 am
[at noodls] - AUSTIN, Texas and NORTHBROOK, Ill., May 23, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) announced today that they have entered into an amendment to the definitive ...
Posted: May 26, 2016, 8:27 pm
[Business Wire] - Ignyta, Inc. , a precision oncology biotechnology company, announced today that Jonathan Lim., M.D., its Chairman and Chief Executive Officer, will make a presentation at the 2016 Jefferies Healthcare Conference on June 8, 2016 at 11:30 a.m.
Posted: May 26, 2016, 8:00 pm
[at noodls] - WALTHAM, Mass., May 26, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading innovator and provider of high-value products to improve the process of manufacturing biologic drugs, today ...
Posted: May 26, 2016, 7:07 pm
[GlobeNewswire] - WALTHAM, Mass., May 26, 2016-- Repligen Corporation, a leading innovator and provider of high-value products to improve the process of manufacturing biologic drugs, today announced that it will participate ...
Posted: May 26, 2016, 6:52 pm
Posted: May 26, 2016, 5:04 pm
[at noodls] - DUBLIN, Ohio--(BUSINESS WIRE)--May 26, 2016-- Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) announces the receipt of an initial notice of award for a Fast- track Small Business Innovation Research ...
Posted: May 26, 2016, 4:47 pm
[Business Wire] - Navidea Biopharmaceuticals, Inc. announces the receipt of an initial notice of award for a Fast- track Small Business Innovation Research grant providing for up to $1.8 million from the National Institutes of Health’s National Cancer Institute to fund evaluation of an investigational Manocept™-based immunotargeted treatment for Kaposi’s Sarcoma .
Posted: May 26, 2016, 4:15 pm